Kalpana Rajanala | Biochemistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kalpana Rajanala | Biochemistry | Best Researcher Award

Manager-Scientific and Medical Writing at Ocugen, United States

Dr. Kalpana Rajanala is an accomplished researcher with a profound understanding of drug development, particularly in the fields of oncology, ocular diseases, laminopathies, and neurodegenerative diseases. Her expertise spans scientific writing, data analysis, and communication, making her a versatile professional in the biomedical research arena.🌟🔬💉

Professional profile

Education📚

Dr. Rajanala holds a Ph.D. in Cellular and Molecular Biology from Jawaharlal Nehru University, New Delhi (2006-2012). She also earned an M.E. in Biotechnology from the Birla Institute of Technology and Science (BITS), Pilani (2004-2006), and a B.S. in Physician Assistance from the Institute of Cardiovascular Diseases, Chennai (2000-2004). Her educational background lays a strong foundation for her multifaceted research career. 📚🔬🏅

Professional Experience🏛️

With a career spanning over a decade, Dr. Rajanala has held key positions in both academia and industry. She currently serves as the Manager of Scientific and Medical Writing at Ocugen, Inc. Her previous roles include editor at Cactus Communications, research scientist at Thomas Jefferson University, and post-doctoral fellowships at the University of Göttingen, Germany, and the National Institute of Immunology, New Delhi. Her diverse professional experience has honed her skills in scientific communication and research. 🧪🔬🔍

Research Interest🌐

Dr. Rajanala’s research interests lie at the intersection of cellular biology and drug development, with a particular focus on the molecular mechanisms underlying diseases such as cancer and ocular disorders. Her work has contributed to the understanding of Golgi fragmentation, epigenetic switches in retinal homeostasis, and therapeutic strategies for geographic atrophy, positioning her as a thought leader in these areas. 🧬🩺🌟

Awards and Honors🏆

Dr. Rajanala’s excellence in research has been recognized with several prestigious awards and fellowships. She received the Fritz Thyssen Fellowship and the Deutscher Akademischer Austauschdienst (DAAD) grant for her research in Germany. She was also awarded the Best Poster Presentation at the International Symposium on Cancer Biology, New Delhi, and earned a Gold Medal during her graduation at the Institute of Cardiovascular Diseases, Chennai. These accolades highlight her significant contributions to the scientific community.🥇🎓🌟

Achievements🏅
  • Ph.D. in Cellular and Molecular Biology from Jawaharlal Nehru University, New Delhi, India.
  • Manager of Scientific and Medical Writing at Ocugen, Inc., leading the preparation of regulatory documents and scientific publications.
  • Recipient of the Fritz Thyssen Fellowship for research at the University of Göttingen, Germany.
  • Awarded Deutscher Akademischer Austauschdienst (DAAD) Grant for studying the targeting of ER membrane proteins in Germany.
  • Best Poster Presentation Award at the International Symposium on Cancer Biology, National Institute of Immunology, New Delhi.
  • Gold Medalist in Graduation at the Institute of Cardiovascular Diseases, Chennai, India.
  • Published multiple research papers in high-impact journals, including the International Journal of Molecular Sciences and Cellular Signaling.
  • Presented research findings at prestigious conferences, including the Experimental Biology Meeting in Philadelphia and the Cold Spring Harbor Laboratory Meeting in New York.
  • Contributed to NIH R21 and R01 grant progress reports at Memorial Sloan Kettering Cancer Center and Thomas Jefferson University.
  • Extensive experience in scientific and medical writing, including authoring manuscripts, grant proposals, and regulatory documents.
Publications top noted📜
  • “Localization of nucleoporin Tpr to the nuclear pore complex is essential for Tpr mediated regulation of the export of unspliced RNA”
    Rajanala, K., Nandicoori, V.K. (2012)
    PloS One, 7(1): e29921.
    Citations: 87
  • “Phosphorylation of nucleoporin Tpr governs its differential localization and is required for its mitotic function”
    Rajanala, K., Sarkar, A., Jhingan, G.D., Priyadarshini, R., Jalan, M., Sengupta, S., et al. (2014)
    Journal of Cell Science, 127(16): 3505-3520.
    Citations: 40
  • “Kinetoplast Morphology and Segregation Pattern as a Marker for Cell Cycle Progression in Leishmania donovani”
    Minocha, N., Kumar, D., Rajanala, K., Saha, S. (2011)
    Journal of Eukaryotic Microbiology, 58(3): 249-253.
    Citations: 38
  • “The distribution pattern of proliferating cell nuclear antigen in the nuclei of Leishmania donovani”
    Kumar, D., Minocha, N., Rajanala, K., Saha, S. (2009)
    Microbiology, 155(11): 3748-3757.
    Citations: 31
  • “Histone H4 lysine 14 acetylation in Leishmania donovani is mediated by the MYST-family protein HAT4”
    Kumar, D., Rajanala, K., Minocha, N., Saha, S. (2012)
    Microbiology, 158(2): 328-337.
    Citations: 29
  • “Emery–Dreifuss muscular dystrophy mutations impair TRC40-mediated targeting of emerin to the inner nuclear membrane”
    Pfaff, J., Rivera Monroy, J., Jamieson, C., Rajanala, K., Vilardi, F., et al. (2016)
    Journal of Cell Science, 129(3): 502-516.
    Citations: 27
  • “Characterization of Leishmania donovani MCM4: expression patterns and interaction with PCNA”
    Minocha, N., Kumar, D., Rajanala, K., Saha, S. (2011)
    PloS One, 6(7): e23107.
    Citations: 15
  • “Gβγ regulates mitotic Golgi fragmentation and G2/M cell cycle progression”
    Rajanala, K., Klayman, L.M., Wedegaertner, P.B. (2021)
    Molecular Biology of the Cell, 32(20): br2.
    Citations: 5
  • “Geographic atrophy: Pathophysiology and current therapeutic strategies”
    Rajanala, K., Dotiwala, F., Upadhyay, A. (2023)
    Frontiers in Ophthalmology, 3: 1327883.
    Citations: 4
  • “In vitro analysis of Hedgehog acyltransferase and porcupine fatty acyltransferase activities”
    Asciolla, J.J., Rajanala, K., Resh, M.D. (2019)
    Protein Lipidation: Methods and Protocols, 243-255.
    Citations: 2
  • “Gβγ signaling regulates microtubule-dependent control of Golgi integrity”
    Rajanala, K., Wedegaertner, P.B. (2023)
    Cellular Signalling, 106: 110630.
    Citations: 1
  • “Correction: Phosphorylation of nucleoporin Tpr governs its differential localization and is required for its mitotic function”
    Rajanala, K., Sarkar, A., Jhingan, G.D., Priyadarshini, R., Jalan, M., Sengupta, S., et al. (2022)
    Journal of Cell Science, 135(6): jcs260004.
    Citations: 1

Mahsa Salehi | Biochemistry | Women Researcher Award

Published on by Global Scholar Awards

🌟Ms. Mahsa Salehi, Biochemistry, Women Researcher Award🏆

 Salehi Tehran university of medical science, Iran

Professional Profiles:

Bio Summary:

Mahsa Salehi is an accomplished Iranian researcher and Ph.D. candidate specializing in Medical Biotechnology. With a keen interest in cancer research, cell therapy, and regenerative medicine, Salehi has demonstrated outstanding academic achievements throughout her educational journey. Her research focuses on the evaluation of extracellular vesicles derived from animal sources as drug delivery vehicles, particularly in hepatocellular carcinoma models. Salehi has an extensive background in laboratory techniques, including extracellular vesicle isolation, cell culture, transfection, and molecular biology methods.

Education:

Ph.D. in Medical Biotechnology (2018 – Present)

Tehran University of Medical Sciences

GPA: 19.5/20; Outstanding Student

Thesis: Evaluation of extracellular vesicles for Sorafenib delivery in hepatocellular carcinoma

M.Sc. in Medical Biotechnology (2015 – 2017)

Isfahan University of Medical Sciences

GPA: 18.91/20; Outstanding Student

Thesis: Knockdown of long non-coding RNA PVT1 in AEL cells

B.Sc. in Anesthesia (2011 – 2015)

Shahrekord University of Medical Sciences

GPA: 18.88/20; Outstanding Student

Research Focus:

Salehi’s primary research interests include:

Cancer research

Cell therapy and regenerative medicine

Extracellular vesicles as diagnostics, therapeutics, or natural drug delivery tools

Professional Journey:

Salehi’s professional journey includes research experiences in evaluating extracellular vesicles for drug delivery, studying the effects of ginger-derived extracellular vesicles on induced ferroptosis, and investigating the inhibition of long non-coding RNA PVT1 in acute erythroleukemia cells. She has contributed significantly to the field with presentations at international conferences and publications in reputable journals.

Honors & Awards:

Member of the National Elite Foundation of Iran

Top student of Medical Biotechnology Department, Tehran University of Medical Sciences (2023)

1st Ranked in Ph.D. Comprehensive Exam

Recipient of Top Student Talent Award for entering the master’s degree without an exam

Several other awards recognizing academic excellence and achievements

Publications Top Noted & Contributions:

alehi has published extensively in reputable journals, covering topics such as milk-derived extracellular vesicles, treatment effects on vesicle characteristics, and the role of exosomal microRNAs in drug resistance. She has also authored chapters in books related to extracellular vesicles and cancer pathogenesis.

Title: Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities

  • Authors: M Salehi, M Sharifi
  • Journal: Journal of Cellular Physiology
  • Volume: 233 (9)
  • Pages: 6370-6380
  • Cited By: 207
  • Year: 2018

Title: Kefir: A powerful probiotic with anticancer properties

  • Authors: M Sharifi, A Moridnia, D Mortazavi, M Salehi, M Bagheri, A Sheikhi
  • Journal: Medical Oncology
  • Volume: 34
  • Pages: 1-7
  • Cited By: 173
  • Year: 2017

Title: Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma

  • Authors: M Salehi, A Movahedpour, A Tayarani, Z Shabaninejad, MH Pourhanifeh, …
  • Journal: Phytotherapy Research
  • Pages: 1-20
  • Cited By: 46
  • Year: 2020

Title: Exosomal noncoding RNAs: Key players in glioblastoma drug resistance

  • Authors: A Movahedpour, SH Khatam, M Khorsand, M Salehi, A Savardashtaki, …
  • Journal: Molecular and Cellular Biochemistry
  • Cited By: 30
  • Year: 2021

Title: Induction of apoptosis and necrosis in human acute erythroleukemia cells by inhibition of long non-coding RNA PVT1

  • Authors: M Salehi, M Sharifi
  • Journal: Molecular Biology Research Communications
  • Volume: 7 (2)
  • Pages: 89-96

Author Metrics:

Citations: 542

h-index: 8

i10-index: 8

These metrics are commonly used to assess the impact and productivity of a researcher. The h-index represents the number of papers (h) that have at least h citations, while the i10-index indicates the number of publications with at least 10 citations

Research Timeline:

2018 – Present: Ph.D. research on extracellular vesicles for drug delivery in hepatocellular carcinoma.

2015 – 2017: M.Sc. research on the knockdown of long non-coding RNA PVT1 in AEL cells.

2011 – 2015: B.Sc. in Anesthesia with outstanding academic performance.

Mahsa Salehi’s research journey reflects a commitment to advancing knowledge in medical biotechnology, particularly in the areas of cancer therapy and extracellular vesicle applications. Her accomplishments highlight a dedication to academic excellence and contribute significantly to the scientific community.